Can Fite BioPharma Ltd (CANF)

[midastouch017]

I would not be surprised to see CANF stock jump higher sometime in September. Adding to the optimism is the broader fundamentals. As I stated above, many vaccine specialists have fallen out of favor as the difficulties of accelerating such solutions become more apparent. Even if they were effective, many people just won’t take them.

However, treatments will never go out of style because they address problems that have already occurred. Further, because the coronavirus can evolve, the versatility and the relative palatability of Piclidenoson may give CANF stock the upper hand in our war against the coronavirus.

More at:

https://emerginggrowth.com/the-one-factor-that-may-distinguish-can-fite-biopharma-canf/